EPS for iShares MSCI Brazil ETF USD Acc (CSBR) Expected At $0.01

September 8, 2018 - By Billy Entrekin

iShares MSCI Brazil ETF USD Acc (NASDAQ:CSBR) Logo

Analysts expect iShares MSCI Brazil ETF USD Acc (NASDAQ:CSBR) to report $0.01 EPS on September, 13.They anticipate $0.07 EPS change or 116.67 % from last quarter’s $-0.06 EPS. CSBR’s profit would be $110,414 giving it 213.75 P/E if the $0.01 EPS is correct. After having $-0.06 EPS previously, iShares MSCI Brazil ETF USD Acc’s analysts see -116.67 % EPS growth. The ETF increased 2.76% or $0.23 during the last trading session, reaching $8.55. About 76,104 shares traded. iShares MSCI Brazil ETF USD Acc (NASDAQ:CSBR) has risen 69.08% since September 8, 2017 and is uptrending. It has outperformed by 56.51% the S&P500.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. The ETF has market cap of $94.40 million. The Company’s Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It currently has negative earnings. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.